Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLEAR-Lung III: Circulating Tumor DNA-Guided Consolidation Chemotherapy and Immunotherapy After Chemoradiation in Unresectable Stage III NSCLC

NCT07858253 is registered in ClinicalTrials.gov with Anusha Chidharla, MD as lead sponsor.

NCT NCT07858253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07858253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLEAR-Lung III: Circulating Tumor DNA-Guided Consolidation Chemotherapy and Immunotherapy After Chemoradiation in Unresectable Stage III NSCLC
Lead sponsor
Anusha Chidharla, MD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2030
Enrollment
43 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer